| Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||
| Research and development expenses, as reported | $ | 292.6 | $ | 268.6 | $ | 591.1 | $ | 537.6 | |||||||
| Share-based compensation expense | (23.7 | ) | (19.8 | ) | (46.6 | ) | (39.9 | ) | |||||||
| Other adjustments | (0.2 | ) | (0.2 | ) | (0.4 | ) | (0.4 | ) | |||||||
| Non-GAAP research and development expenses | $ | 268.7 | $ | 248.6 | $ | 544.1 | $ | 497.3 | |||||||
| GAAP research and development expenses as a percentage of net sales | 13.0 | % | 13.0 | % | 13.0 | % | 13.3 | % | |||||||
| Non-GAAP research and development expenses as a percentage of net sales | 11.9 | % | 12.0 | % | 12.0 | % | 12.3 | % | |||||||
Microchip Technology Announces Financial Results For Second Quarter of Fiscal Year 2024
 |  | More IC News
|
|
RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES
RELATED NEWS
